| INTRODUCTION
The prevalence of allergy is increasing in Europe where it has been predicted that over 50% of the population will have some form of allergy by 2050, 1,2 with a most dramatic increase in children whose quality of life is severely affected. 3 The annual cost of allergic diseases for national health systems is as high as for seasonal influenza, 4 and it has been estimated that the annual cost of food allergy exceeds thousands of millions of euros in Europe alone. 5 Even though the role of proteins in allergic sensitization has been extensively studied, 6 ,7 the reasons why a specific protein may have allergenic activity are not yet well understood. Several hundred protein allergens have been described (www.allergen.org) and a large number of their epitopes identified. 8 However, only 1% of known protein families include allergens and besides, not all the members of those families are allergenic. [6] [7] [8] Although no biochemical feature common to allergenic proteins has been found, more than 50% of allergens have been shown to be lipid carriers, including Bet v 1 (the major allergen of birch pollen) and 2S allergens, which contain a large hydrophobic pocket able to harbour and store many lipid compounds and flavonoids as well. [8] [9] [10] Recently, the ligand of Pru p 3, the peach allergenic lipid transfer protein (LTP), has been identified as a derivative of the alkaloid camptothecin bound to phytosphingosine ( Figure 1A ), a lipid tail which is inserted into the Pru p 3 cavity. 9 Phytosphingosine is a structural component in membranes, 10 while camptothecin is widely used as a chemotherapeutic agent for its ability to inhibit the enzymatic activity of topoisomerase I.
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Lipid ligands carried by allergens, or exposed together, might influence the host response to the specific allergen. Accordingly, immuneregulatory lipids could significantly contribute to the allergenicity of several proteins. 12 All of these molecules are attractive candidates as non-self structures recognized by the innate immune system as being capable of inducing Th2-skewed responses that contribute to allergy in susceptible individuals. 13 Lipids from the pollen coat and furry animals as well as the so-called pollen-associated lipid mediators are codelivered together with the allergens and can modulate the immune responses of predisposed subjects by interacting with the innate immune system and invariant natural killer T (iNKT) cells. 13 iNKT cells are innate-like T lymphocytes with important immunomodulatory properties that can be damaging (eg allergic inflammation) or protective (eg maintenance of transplant tolerance, inhibition of autoimmunity). 14 They express glycolipid-reactive ab T cell receptors (TCRs) together with several characteristic markers of NK cells and they are "CD1-restricted". 15 The CD1-receptor family includes monomorphic major histocompatibility complex (MHC) class I-like glycoproteins that can present lipid antigens. The CD1 family in humans has five members, namely CD1a-e, while rodents only express CD1d. 16 Given the non-polar nature of lipids, their mobilization across an aqueous endocytic environment likely requires extraction from membranes and, in most of the cases, transport across aqueous biological buffers into the lipid-binding grooves of CD1 molecules.
The results presented in the current report suggest that the lipid-ligand carried by the peach allergen Pru p 3 could act as an adjuvant with the ability to modulate the immune system towards a To carry out the assays, the recombinant Pru p 3 protein was used. In this way, the absence of pollutants (lipid-ligand residues) in the purified protein was ensured. As "complex", it is referred to the mix of Pru p 3 and its purified ligand (10:1). The ratio was determined by binding assays between Pru p 3 and the lipid-ligand as previously described. 9 The recombinant Pru p 3 was produced in P Pastoris and isolated using the methods describe by Diaz-Perales et al. (2002) . 17 The presence of endotoxin in the protein samples was measured using the Pierce LAL (Table S1 ). The statistical analysis was performed using the two-way ANOVA with corrections for multiple comparisons. P-values <.001 were considered significant. Then, cytokines with statistically significant difference were also represented as fold change calculated as the ratio between the amount of cytokines present in the culture with stimulus and the cytokine content of the control without stimulation.
| Generation of human antigen-presenting cells (moDC)
Monocytes were purified from human PBMCs by positive selection using CD14 Dynabeads (Invitrogen), following the manufacturer's protocol. Purity was assessed by flow cytometry (BD Accuri Cytometers, San Jose, CA USA) and found to be higher than 95%. Dendritic cells (DCs) were derived from monocytes (moDC) by culturing the CD14 + fraction in complete medium RPMI (Invitrogen) with L-glutamine (brand, country), 10% heat-inactivated fetal bovine serum (FBS, Lonza, Germany), 100 mg/mL antibiotics (streptomycin and penicillin; Invitrogen), 200 ng/mL rhIL4 and 100 ng/mL rhGM-CSF (Immunotools, Friesoythe Germany) for 4-5 days at 5% CO 2 and 37°C, as described previously. 19 Immature DCs (iDCs) derived from mono- 
| Antibody measurement
during 48 hours. Subsequently, 5910 7 beads/mL were incubated with a-galactosylceramide (5 lg; Sigma) as a positive control,
| Statistical analyses
Statistical analyses were performed using SPSS 17.0 and GraphPad 6. The t test, Kruskal-Wallis test, one-way ANOVA and two-way ANOVA with corrections for multiple comparisons were used when applicable. P-values <.05 were considered significant for all assays.
| Structural analyses
For Pru p 3, the chain B of the crystal structure PDB id. 3 | RESULTS
| The lipid-ligand of Pru p 3 is responsible for the activation of antigen-presenting cells
The immunological activity of Pru p 3 with or without its lipid-ligand was investigated using human PBMCs obtained from four healthy donors. PBMCs were stained with CSFE and after that, Pru p 3 and the complex were added. On the 5th day, PBMCs proliferation was quantified by flow cytometer, with strong activation in the presence of the ligand ( Figure 1B ; P≤.001). This activation was also measured as the production of pro-inflammatory cytokines (Table S1 ). Significant differences were only observed in the production of IL8, IL10,
INFc, but especially in the production of IL13 in the presence of ligand ( Figure 1C ).
In the same way, moDCs derived from peripheral blood of the same donors were also incubated with Pru p 3 and its ligand. As shown in Figure 1D , the presence of the lipid-ligand gave rise to significant induction of the maturation markers CD80 and CD86, while no changes were observed when only Pru p 3 was utilized (P≤.001).
Moreover, the immunological activity of the lipid-ligand was also confirmed using THP1-XBlue 
| The lipid-ligand of Pru p 3 increases the capacity to sensitize mice through the epicutaneous route
To determine the role of the lipid-ligand of Pru p 3 in inducing allergic sensitization, mice were epicutaneously exposed to Pru p 3, with or without its lipid-ligand, once a week for 6 weeks, following a previously described protocol 27 ( Figure 2A ). Briefly, hair was removed with depilatory cream, but no tape stripping was performed and the antigen was added topically in PBS without occlusive bandages.
After 6 weeks of sensitization, blood was obtained for basophil activation test and specific immunoglobulin measurement. Mice exposed to Pru p 3 plus its lipid-ligand (Complex in Figure 2B ) developed significantly more Pru p 3-specific IgE than Pru p 3 alone (Pru p 3, Figure 2B ), while IgG1 levels were similar in both cases. Similarly, basophil activation was increased in mice sensitized with the complex, as reflected by a higher increase in CD200R MFI ( Figure 2C ).
Despite the differences in IgE induction, when mice were intraperitoneally challenged with Pru p 3, no differences were observed in terms of drop in body temperature during anaphylactic responses ( Figure 2D ).
| Pru p 3 is bound by CD1d in the presence of the lipid-ligand
To determine which receptor mediated the recognition of the lipidligand, specific antibodies to TLR2, TLR4 and CD1d (receptors that recognize lipid ligands) were added to Pru p 3-moDCs cultures and DC maturation was studied. Maturation of human moDC could be only inhibited in presence of anti-CD1d ( Figure 3A ), but not with polyclonal antibodies anti-TLR2 or anti-TLR4 (P<.001).
In the same way, polarized epithelial monolayers (Caco2 cells, Figure 3B ) were also incubated with Pru p 3 (Pru p 3) and complex (Complex), during short times (5 minutes). After fixing cells, immune receptors (PRR) such as TLR2, TLR4 and CD1d were localized using specific antibodies. In the presence of the ligand, Pru p 3 co-localized with CD1d-type receptors ( Figure 3C ) but not when Pru p 3 was alone ( Figure 3D ). In the case of TLR2 and TLR4, no differences in localization were observed in the presence of absence of the lipid-ligand ( Figure S1 ).
| The lipid-ligand presented by CD1d could stimulate iNKTs
According to the results above described, we studied the role of the lipid-ligand in the activation of iNKT cells through CD1d receptor. Figure 4A ).
To further demonstrate that the lipid-ligand could interact with iNKTs through the CD1d receptor, the lipid-ligand was incubated with a CD1d unloaded human dextramer according to the manufacturer's instructions. This probe is capable of binding to the TCR present on the surface of iNKTs provided it has the appropriate lipid.
As can be seen in Figure 4B , the fluorescent probe loaded with the lipid-ligand (labelled with APC) was able to interact with iNKT cells (labelled with FITC). In fact, most of the lipid-ligand-CD1d probes bound specifically to iNKTs ( Figure 4B ). In the Figure 4C , it could be observed two examples of iNKT cell surrounded by CD1d-tetramerslipid-ligand probe labelled with APC (red). Figure 5B ). The architecture of saposins also present some particular features: (i) the longest helix has a highly localized kink associated with a local disruption of two main-chain hydrogen bonds around a conserved Tyr54 residue which is not the classic example of disruption caused by a proline, (ii) the shortest a4 helix starts at a conserved proline and (iii) with the exception of saposin C, they also have short 3 10 helices ( Figure 5A ,B).
The structure of Pru p 3 ( Figure 5C ) presents significant structural similarities to saposins. Not only Pru p 3 has a similar architecture with four a helices, one 3 10 helix and disulphide bonds (four instead of three in saposins), but it also displays particular structural features analogous to those indicated above for saposins. In fact, Pru p 3 presents a kink in the longest a helix (although the disruption of main-chain hydrogen bonds is caused by a proline), its shortest a4 helix starts also at a proline and it exhibits also a three-residue 3 10 helix (Figure 5A,D) . Besides these In any event, we have shown in this work that the lipid-ligand of Pru p 3, perhaps especially its phytosphingosine domain, is presented to iNKT cells by CD1 receptors. Although it is likely that this is not the only innate immune pathway involved in the recognition of Pru p 3, our results reveal that it is active in moDC and epithelial mucosa. This is not the first report associating iNKTs to allergen activation. iNKTs can be activated by phospholipids, particularly phosphatidylethanolamine and phosphatidylcholine present on the surface of cypress nuts. 16 A recent study analysed the general ability of olive pollen lipids to activate DCs and stimulate iNKT cells and demonstrated that polar lipids isolated from olive pollen grains upregulated CD1d on DCs, which then activated iNKT cells in co-cultures. 38 In the same way, the 2S albumin from Brazil nut, Ber e 1,
was not sufficient to cause IgE or IgG production in mice. 39 In contrast, the co-administration of the allergen with polar lipid fractions isolated from the same nut induced the production of Ber e 1-specific IgE and IgG1. In the absence of iNKT cells, the specific IgE levels were lower. 40 Lastly, it has been suggested that the activation of iNKT cells induce Th2-mediated inflammation to cow's milk-derived sphingolipids. 
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